PB.40. What happens to the ductal carcinomain situin HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
R Millican-Slater,D Dodwell,K Horgan,M Mcmahon,B Dall…Volume:
16
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/bcr3735
Date:
December, 2014
File:
PDF, 442 KB
english, 2014